Page 303 - Read Online
P. 303

Cervantes-Gracia et al. Vessel Plus 2020;4:27                               Vessel Plus
               DOI: 10.20517/2574-1209.2020.22




               Review                                                                        Open Access


               Oxidative stress and inflammation in the
               development of cardiovascular disease and contrast

               induced nephropathy


               Karla Cervantes-Gracia , Khuram Raja , Daniel Llanas-Cornejo , James N. Cobley , Ian L. Megson ,
                                                                      3
                                                                                                    2
                                                                                      2
                                                 2,*
                                   1,*
               Richard Chahwan , Holger Husi 2,4
                              1
               1 Institute of Experimental Immunology, University of Zurich, Zurich 8057, Switzerland.
               2 Division of Biomedical Sciences, Institute of Health Research and Innovation, University of the Highlands and Islands, Inverness
               IV2 3JH, United Kingdom.
               3 Health Sciences Division, Universidad de Monterrey, Monterrey 66238, Mexico.
               4 Institute of Cardiovascular and Medical Sciences, University of Glasgow, BHF Glasgow Cardiovascular Research Centre,
               Glasgow G12 8TA, United Kingdom.
               *These authors contributed equally.
               Correspondence to: Dr. Holger Husi, Division of Biomedical Sciences, Institute of Health Research and Innovation, University of
               the Highlands and Islands, Old Perth Road, Inverness IV2 3JH, United Kingdom. E-mail: Holger.Husi@uhi.ac.uk
               How to cite this article: Cervantes-Gracia K, Raja K, Llanas-Cornejo D, Cobley JN, Megson IL, Chahwan R, Husi H. Oxidative
               stress and inflammation in the development of cardiovascular disease and contrast induced nephropathy. Vessel Plus 2020;4:27.
               http://dx.doi.org/10.20517/2574-1209.2020.22
 Received:    First Decision:    Revised:    Accepted:    Published: x
               Received: 1 Jun 2020    First Decision: 30 Jun 2020    Revised: 3 Jul 2020    Accepted: 10 Jul 2020    Published: 1 Sep 2020
 Science Editor:    Copy Editor:    Production Editor: Jing Yu
               Academic Editor: Cristina Vassalle, Laura Sabatino    Copy Editor: Cai-Hong Wang    Production Editor: Jing Yu



               Abstract
               Utilization of contrast media to visualize vasculature structures in the setting of cardiovascular disorders (CVD)
               can lead to acute kidney injury, referred to as contrast-induced nephropathy (CIN). CIN can potentiate mortality
               and hospitalization in aged individuals, patients with CVD, nephropathy, enhancing kidney damage, and cardiac
               events. Preventing CIN by identifying risk factors is important. The underlying mechanisms of CIN pathology are
               unclear, but the key factors include direct cytotoxicity, oxidative stress, vascular and endothelial dysfunction and
               inflammatory processes. Reactive Oxygen Species and inflammatory mediators have been proposed as key factors
               influencing the development of CIN and CVD, and the elucidation of the interplay between the mechanisms
               evoked by them may provide a better understanding of the signaling processes happening in these conditions,
               thereby potentially enabling early identification, prevention and characterization of novel drug targets.


               Keywords: Contrast induced nephropathy, cardiovascular disorders, oxidative stress, inflammation, reactive
               oxygen species



                           © The Author(s) 2020. Open Access This article is licensed under a Creative Commons Attribution 4.0
                           International License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use,
                sharing, adaptation, distribution and reproduction in any medium or format, for any purpose, even commercially, as long
                as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license,
                and indicate if changes were made.


                                                                                                                                                       www.vpjournal.net
   298   299   300   301   302   303   304   305   306   307   308